MMMartin E. Matsumura

Martin E. Matsumura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Martin E. Matsumura has a total of 109 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pyrophosphatase 2 Deficiency: Clinical Presentation, Diagnosis and Management

    by Hayley Nehoff, Ian Crozier, Hilary Vernon, Christine James, Ana I. Fernández-Ávila, Michael Bowes, Esther Gomez-Gonzalez, Colin Phoon, Kristy DiLoreto, Martin E. Matsumura, et al.

    BACKGROUND: PPA2 (pyrophosphatase 2) deficiency is a relatively newly recognized condition caused by biallelic variants in the PPA2 gene. The gene encodes the mitochondrial enzyme PPA2, involved in the production of orthophosphate in the mitochondrial matrix. Affected individuals typically present with sudden cardiac death or acute heart failure following common viral illnesses in infants and toddlers, or following exposure to small amounts of alcohol as teenagers. The condition has a high mortality rate in these situations. Here, we explore the clinical presentations and current management of these patients with a view to guiding future emergency clinical management of cases. METHODS: Case records from published and unpublished affected individuals diagnosed with PPA2 deficiency were compiled in a retrospective cohort study of genotypes, phenotypes and clinical management protocols in individuals with biallelic (likely) pathogenic PPA2 variants. RESULTS: We collated 93 affected individuals from 53 families, 14 of which have not previously been reported. Patient presentation is invariably acute, often associated with fatigue, vomiting, seizures and collapse. Generally, presenting individuals received standard emergency management with cardiopulmonary resuscitation and appropriate management of arrhythmia, and here we present compiled clinical management protocols for emergency and ongoing treatment of PPA2-deficient patients. A pronounced inheritance rate of pathogenic alleles from carrier parents is noted, and further research is warranted to confirm and investigate any selective advantage for gametes carrying pathogenic PPA2 variants. CONCLUSIONS: PPA2 deficiency has a high mortality rate following exposure to common childhood viruses in children around and under the age of 3 and in teenagers exposed to ethanol. We have presented current therapeutic approaches gathered from a worldwide survey of clinicians treating their patients, possible pathogenic mechanisms and inheritance peculiarities of the condition and provide a comprehensive review of the current recommendations surrounding patients’ clinical management.

  • Trends in Cardiovascular Mortality Associated With Systemic Connective Tissue Disorders in the United States: A 22‐Year Population‐Based National Analysis (1999–2020)

    by Chukwuemeka Christian Aghasili, Reuben Laryea Odai, Samuel A. Mensah, Manfred Mate‐Kole, Nathaniel Eyiah, Timothy Kopah, Albert Orhin, Isaac Adjei Opoku, Ikponmwosa Jude Ogieuhi, Gregory I. Atafo, et al.

    Aim: To examine national trends and disparities in cardiovascular mortality associated with systemic connective tissue disorders (CTDs) in the United States from 1999 to 2020. Methods: We analyzed mortality data from the CDC WONDER database. Deaths were included where CTD (ICD‐10: M05, M06, M30–M35) was the underlying cause and cardiovascular disease was a contributing cause. Age‐adjusted mortality rates (AAMRs) per 1 000 000 were calculated using the 2000 US Standard Population. Joinpoint regression identified annual and average annual percentage changes. Analyses were stratified by sex, race/ethnicity, census region, and urbanization. Disease subgroup and state‐level analyses were performed. Results: Between 1999 and 2020, 47 752 cardiovascular deaths occurred among individuals with systemic CTDs. The national AAMR declined from 14.4 to 8.2 per 1 000 000 (AAPC: −2.68%, 95% CI: −2.89 to −2.47, p < 0.001). Females had consistently higher mortality than males (average AAMR: 13.5 vs. 5.9 per 1 000 000; p < 0.001). Non‐Hispanic Black individuals had the highest rates (average AAMR: 14.9 per 1 000 000), with widening disparities after 2008. Rural areas had higher mortality than urban areas (average AAMR: 11.4 vs. 9.9 per 1 000 000; p = 0.01). Subgroup analyses revealed heterogeneous trends across CTD subtypes, with SLE showing the slowest improvement (AAPC: −1.87%) and dermatomyositis the steepest decline (AAPC: −4.98%). State‐level AAMRs ranged 2.2‐fold, from 6.3 (District of Columbia) to 13.6 (Montana) per 1 000 000. Conclusions: Cardiovascular mortality associated with systemic CTDs has declined significantly over two decades; however, persistent racial disparities, urban–rural differences, heterogeneous disease‐specific trends, and substantial geographic variation underscore the need for targeted, equitable interventions in this high‐risk population.

  • Open Access

    Delivering virtual cardiac rehabilitation within correctional facilities to fulfill the decree of Estelle versus Gamble

    by Martin E. Matsumura, Favour Nelson, Alex Zimmerman, Cinde L. Bower-Stout, Thomas S. Matsumura, Bryan Martin

    Incarcerated individuals suffer from significant inequity of access to health care, a reality that has been the subject of prior high court decisions. This case report highlights the use of a “virtual” telemedicine modality to improve the limited access to evidence-based care, specifically cardiac rehabilitation post myocardial infarction, among incarcerated individuals.

  • Open Access

    Integrating Prior Qualitative Coronary Artery Calcium Assessment into an Established Chest Pain Algorithm: Effect on Risk Stratification Outcomes

    by Aradhya Abrol, Smith Frimpong, Rifla Hassan, Dima Khalil, Samuel Schwartzwald, Martin E. Matsumura

    Background: Chest pain (CP) patients with moderate elevations of high sensitivity cardiac troponins benefit from additional risk stratification strategies to improve Emergency Department decision-making. In the present study we evaluated the impact of adding the results of opportunistic detection of coronary calcium (ODCAC) from prior routine chest computed tomography scans (CT) to both high sensitivity troponin T (hsTnT) accelerated diagnostic protocol and determination of the HEART score (HS). Methods: Retrospective study of 1,525 consecutive patients evaluated for CP with moderate peak elevations of hsTnT (12-51 ng/L). Thirty-day major adverse cardiovascular events (MACE) were assessed based on peak hsTnT, HS, and ODCAC on chest CT performed within 5 years of CP presentation. Firth’s penalized logistic regression was employed to assess the combined predictive power of these variables. Results: The median age of the cohort was 69, 59% were male, and 81% had ODCAC on review of chest CT. Patients with MACE had higher peak hsTnT, median HS, and higher proportion of ODCAC+ versus those without MACE. Absence of ODCAC demonstrated a negative predictive value of 99.1% for excluding MACE. A logistic regression model including peak hsTnT, HS and ODCAC was successfully fitted (model p=0.002) and revealed that peak hsTnT was the strongest predictor of MACE (OR 1.05 per unit increase, 95% CI 1.02-1.09, p=0.005). A HEART score >3 had borderline-significant association (OR 14.71, 95% CI 0.88-246.19, p=0.061). In this comprehensive model the direct statistical effect of ODCAC was attenuated (p=0.111). Conclusion: The presence of ODCAC was a predictor of and its absence yielded a high negative predictive value for MACE. However, ODCAC did not add incremental risk stratification to a risk algorithm including hsTnT and HS. The lack of additive prognostic value of ODCAC in this particular cohort may be related to the advanced age and resultant high background rate of CAC.

  • Open Access

    Retrospective Comparison of Outcomes and Cost of Virtual Versus Center‐Based Cardiac Rehabilitation Programs

    by Neil D. Shah, Conor W. Banta, Andrea L. Berger, Andrea Hattenberger, Alex Zimmerman, Bryan E. Martin, Edward Wu, Usnish Majumdar, H. Lester Kirchner, Martin E. Matsumura

    Background: Despite robust evidence supporting an association with improved outcomes in eligible patients, cardiac rehabilitation (CR) remains underused, with a minority of eligible patients participating. Virtual cardiac rehabilitation (VCR) has been proposed as an alternative to traditional center‐based CR (CBCR) to improve usage rates. However, data supporting the efficacy and cost‐effectiveness of VCR are limited. In the present study, we compared the outcomes and cost of a VCR versus traditional CBCR program. Methods and Results: In a retrospective cohort study comparing VCR versus CBCR, CBCR data were collected from a period of January 2018 to September 2023. VCR data were collected from program initiation in July 2021 to September 2023. Primary health outcomes measured were 1‐year mortality rates, recurrent myocardial infarction, all‐cause hospital readmission, and emergency department visits. Primary cost outcomes were analyzed as cost ratios related to VCR versus CBCR assessing total medical costs allowed, pharmacy costs, and total costs of care over the 12 months post‐CR enrollment. VCR was associated with a significant reduction in 1‐year all‐cause hospital readmission (incident rate ratio [IRR], 0.616 [95% CI, 0.489–0.777], P P P =0.0144) and total costs allowed (cost ratio, 0.838 [95% CI, 0.725–0.970], P =0.0176). Conclusions: VCR is a viable alternative to CBCR with at least comparable efficacy and cost, and as such, represents a key mechanism for improving access to and participation in CR for eligible patients.


  • Open Access

    Effect of a HEART Score Best Practice Alert on Discharge Decisions and Outcomes of Patients Presenting to an Emergency Department with Chest Pain

    by Adrianna Vaskas, Kyle Marshall, Ria Garg, Ciaran Fisher, Cindi L. Bower-Stout, Muzna Hussain, Martin E. Matsumura


  • Open Access

    Retrospective Comparison of Outcomes and Cost of a Virtual vs. Center-Based Cardiac Rehabilitation Program

    by Neil D. Shah, Conor W. Banta, Andrea L. Berger, Andrea Hattenberger, Alex Zimmerman, Bryan E. Martin, Edward Wu, Usnish Majumdar, H. Lester Kirchner, Martin E. Matsumura

    Background Despite robust evidence supporting an association with improved outcomes in eligible patients, cardiac rehabilitation (CR) remains underutilized, with a minority of eligible patients participating. Virtual cardiac rehabilitation (VCR) has been proposed as an alternative to traditional center-based CR (CBCR) to improve utilization rates. However, data supporting the efficacy and cost-effectiveness of VCR is limited. In the present study, we compared the outcomes and cost of a VCR vs. traditional CBCR program. Methods Retrospective cohort study comparing VCR vs. CBCR. CBCR data were collected from a period of January 2018 to September 2023. VCR data were collected from program initiation in July 2021 to September 2023. Primary health outcomes measured were 1-year mortality rates, recurrent MI, all-cause hospital readmission, and emergency department visits. Primary cost outcomes were analyzed as cost ratios related to VCR vs. CBCR assessing total medical costs allowed, pharmacy costs, and total costs of care over the 12 months post-CR enrollment. Results VCR was associated with a significant reduction in 1-year all-cause hospital readmission (incident rate ratio (IRR)=0.616, 95% confidence interval (CI): 0.489, 0.777, pConclusion VCR is a viable alternative to CBCR with at least comparable efficacy and cost, and as such, represents a key mechanism for improving access to and participation in CR for eligible patients.

  • Open Access

    Political orientation of online media sources and reporting of Covid-19 vaccine myocarditis

    by Addison Matsumura, Ria Garg, Muzna Hussain, Martin E Matsumura

    Background: Political orientation may play a formative role in perceptions of risk associated with COVID-19 vaccination including vaccine myocarditis (CVM). Whether political alignment of news sources plays a role in perception of this risk is unknown. Objective: We examined the relationship between political orientation of online media sites and aspects of reporting of CVM. Methods: Media sites were classified as “left” or “right" biased using the Allsides media bias rating report. For each site “COVID vaccine myocarditis” was searched in articles posted May 2021 to December 2022. Each search return was reviewed for the following: 1) Did it contain numerical data regarding CVM risk? 2) Did it report benefits of covid vaccination? 3) Did it mention covid infection-related myocarditis? Monthly reports of vaccine-related adverse events were obtained from the Vaccine Adverse Events Reporting System (VAERS). Results: A total of 487 online reports regarding CVM were reviewed. Comparison of monthly report volumes from left vs. right biased media sources demonstrated significant correlation (r = 0.546, p = 0.013). Additionally monthly reporting of CVM was temporally related to monthly volume of VAERS reporting (r = 0.519, p = 0.023). These data suggest that monthly reporting volumes were driven by availability of information regarding CVM rather than media political alignment. Left biased media sources were significantly more likely to include numerical CVM data vs. right biased sources (76.6% vs. 24.3%, p<0.001) and likewise were more likely to include data supporting benefits of covid vaccination (85.1% vs. 21.7%. p<0.001). In contrast, there was no difference regarding mention of COVID-19 infection-related myocarditis (24.5% vs. 24.3%, p = 0.957). Conclusion: Political orientation of online news sites was not associated with frequency of CVM reports but was related to report content, most notably whether reports included numerical data regarding CVM risk. These differential reporting characteristics may contribute to the relationship between political orientation and patient conceptualization of risk of CVM.


  • Open Access

    Association of Chest Pain Protocol–Discordant Discharge With Outcomes Among Emergency Department Patients With Modest Elevations of High-Sensitivity Troponin

    by Ayesha Khan, Muhammad S. Saleem, Keith D. Willner, Luke Sullivan, Elsie Yu, Osama Mahmoud, Amro Alsaid, Martin E. Matsumura

    Importance: Accelerated diagnostic protocols (ADPs) for chest pain using high-sensitivity troponin (hsTn) levels have excellent sensitivity and negative predictive value for rapid risk stratification of patients with chest pain. However, little is known about the outcomes of patients who are discharged despite abnormal ADP results, ie, after “ruling-in” with a modest elevation of hsTn.Objective: To determine outcomes of patients discharged following ADP, including those who were ruled in with modestly elevated levels of hsTnT but discharged nonetheless.Design, Setting, and Participants: This retrospective cohort study included patients with chest pain who presented to the emergency departments (EDs) of a large multisite health system ED between January 2017 to September 2019. Patients were assessed using an ADP, had a peak hsTnT level measured between the limit of quantitation and 52 ng/L, were discharged, and had follow-up in the electronic medical record. Data analysis was conducted from January 2017 to September 2019.Exposures: Application of an hsTnT ADP.Main Outcomes and Measures: Thirty-day major adverse cardiac events (MACE), including myocardial infarction, urgent coronary revascularization, and all-cause death, comparing patients who were discharged following ADP-concordant vs ADP-discordant results.Results: Of 10 342 patients with chest pain (mean [SD] age 51 [17] years; 5902 [57%] women) discharged following ADP, 29 (0.28%) had MACE. Patients with MACE were older (median [IQR] age, 66 [53-75] years vs 50 [38-62] years; P < .001) and more likely to have prior CAD (12 [41.4%] vs 1805 [17.5%]; P = .002) and hyperlipidemia (13 [44.8%] vs 2248 [21.8%]; P = .006). Additionally, patients with MACE were 5-fold more likely to have been discharged despite ADP discordance (16 [55.2%] vs 1145 [11.1%]; P < .001). A multivariable logistic regression analysis revealed only ADP discordance was independently associated with MACE (odds ratio, 6.42 [95% CI, 2.94-14.0]; P < .001). When stratified by peak hsTnT level, there were no differences in MACE between ADP-concordant and -discordant discharges provided the peak hsTnT measured was less than 12 ng/L. In contrast, patients with peak hsTnT level between 12 and 51 ng/L were significantly more likely to have MACE if they were discharged after ADP-discordant vs -concordant hsTnT series (14 of 609 [2.30%] vs 5 of 1047 [0.48%]; P < .002). Notably, a HEART (history, electrocardiogram, age, risk factors, troponin) score of 4 or greater retrospectively identified the most ADP-discordant discharges (13 of 16 [81.3%]) who had MACE.Conclusions and Relevance: In this cohort study, an hsTnT ADP identified patients who could be discharged from the ED with low 30-day risk of MACE, provided the discharge was based on ADP-concordant “rule-out.” Conversely, the rate of MACE was significantly higher among patients discharged despite ADP discordance. Most patients with ADP-discordant discharges who experienced MACE had a HEART score of 4 or greater, suggesting that application of this score may augment discharge decisions of patients despite ADP-discordant troponin series.